NCT06585410 2026-04-22
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Recruiting
Regeneron Pharmaceuticals
University of Michigan Rogel Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center